Thalidomide to be tested for use against lung cancer

Research into the efficacy of Thalidomide as a treatment for small cell lung cancer, which is backed by the Cancer Research Campaign (CRC), will be carried out on a total of 30 patients in London and Leeds, UK. Patients will receive one 100 mg tablet of the drug every night for two years alongside traditional chemotherapy.Thalidomide seems to work by stabilising blood flow around tumours, thereby allowing better supply of the chemotherapy agents to the cancerous cells.

By | January 26, 2001

Research into the efficacy of Thalidomide as a treatment for small cell lung cancer, which is backed by the Cancer Research Campaign (CRC), will be carried out on a total of 30 patients in London and Leeds, UK. Patients will receive one 100 mg tablet of the drug every night for two years alongside traditional chemotherapy.

Thalidomide seems to work by stabilising blood flow around tumours, thereby allowing better supply of the chemotherapy agents to the cancerous cells. It then goes on to prevent the growth of further blood vessels, halting tumour growth. The drug has recently been shown to be a highly effective treatment for multiple myeloma and Kaposi's sarcoma, as well as for HIV and rheumatoid arthritis and is an unlicensed indication for leprosy patients who are corticosteroid resistant.

Siow Ming Lee, one of the researchers, commented: "Existing treatments for small cell lung cancer remain unsatisfactory and clearly finding new ways to improve the treatment of this disease is vitally important."

The Thalidomide Society said that it would back any research into the drug's use, provided strict guidelines were observed. Research is also being carried out at Dundee University on the use of thalidomide for treating high and low-risk myelodysplasia

Popular Now

  1. Monsanto Buys Rights to CRISPR
    The Nutshell Monsanto Buys Rights to CRISPR

    The US agribusiness secures a global, nonexclusive licensing agreement from the Broad Institute to use the gene-editing technology for agricultural applications.

  2. How Plants Evolved Different Ways to Make Caffeine
  3. ESP on Trial
    Foundations ESP on Trial

    In the 1930s, parapsychologist Joseph Banks Rhine aimed to use scientific methods to confirm the existence of extrasensory perception, but faced criticisms of dubious analyses and irreproducible results.

  4. Another DNA Vaccine for Zika Shows Promise
RayBiotech